ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
-0,04%
Bitcoin
62.746,44
-1,56%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sangamo Therapeutics Inc (SGMO)

  7. Sangamo Therapeutics Inc (SGMO) News

SGMO Sangamo Therapeutics Inc

0,5101
0,0071 (1,41%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,0071 1,41% 0,5101 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,52 0,503 0,5339 0,5178 0,503
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.4.202422:35BWSangamo Therapeutics to Present Neurology-Focused..
22.3.202413:05BWSangamo Therapeutics Announces Pricing of $24.0 Million..
13.3.202413:05BWSangamo Therapeutics Reports Recent Business Highlights and..
13.3.202413:01BWSangamo Therapeutics Announces Data From Novel Proprietary..
12.3.202423:30BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
27.2.202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202414:05BWSangamo Therapeutics Announces U.S. FDA Alignment on..
06.2.202422:35EDGAR2Form 8-K - Current report
06.2.202400:01BWSangamo Therapeutics Announces Updated Phase 1/2 STAAR Study..
26.1.202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.1.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202423:09EDGAR2Form 8-K - Current report
13.12.202313:55EDGAR2Form 8-K - Current report
28.11.202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202321:02EDGAR2Form 8-K - Current report
01.11.202321:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202321:02EDGAR2Form 8-K - Current report
01.11.202321:01BWSangamo Therapeutics Announces Strategic Update and Reports..
25.10.202322:15BWSangamo Therapeutics Announces Third Quarter 2023 Conference..
24.10.202308:01BWSangamo Therapeutics to Present Pre-Clinical Data Showcasing..
20.9.202322:15BWSangamo Therapeutics to Present at the Jefferies Cell &..
29.8.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202322:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.8.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:08EDGAR2Form 8-K - Current report
08.8.202322:01BWSangamo Therapeutics Reports Recent Business Highlights and..
01.8.202322:15BWSangamo Therapeutics Announces Second Quarter 2023..
20.7.202314:05BWSangamo Therapeutics and Chroma Medicine Announce Option and..
17.7.202314:05BWSangamo Therapeutics Announces Research Evaluation and..
29.6.202314:05BWSangamo Therapeutics and Voyager Therapeutics Enter License..

Kürzlich von Ihnen besucht

NASDAQ
SGMO
Sangamo Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten